Introduction of long non-coding RNAs to regulate autophagy-associated therapy resistance in cancer

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Biology

Background:

• Autophagy, a lysosomal degradation pathway, is regulated by autophagy-related genes (ATGs) and is implicated in cancer development.
• Cancer therapies like chemotherapy and radiotherapy improve survival but are often limited by therapy resistance, leading to poor patient prognosis.
• Long non-coding RNAs (lncRNAs) are emerging as critical regulators of cellular processes, including autophagy.

Purpose of the Study:

• To systematically review and elucidate the role of lncRNAs in mediating chemoresistance and radioresistance in cancer through the regulation of autophagy.
• To explore the mechanisms by which lncRNAs influence autophagy-related signaling pathways, such as the PI3K/AKT/mTOR pathway, in the context of cancer therapy resistance.

Main Methods:

• Literature review of studies investigating the relationship between lncRNAs, autophagy, and cancer therapy resistance.
• Analysis of research on lncRNA regulation of autophagy-related genes (ATGs) and signaling pathways.
• Synthesis of findings on the impact of lncRNAs on chemoresistance and radioresistance.

Main Results:

• lncRNAs are identified as crucial regulators that modulate autophagy by affecting ATGs and key signaling pathways like PI3K/AKT/mTOR.
• Dysregulation of lncRNA-mediated autophagy significantly contributes to the development of chemoresistance and radioresistance in various cancer types.
• Specific lncRNAs have been shown to either promote or inhibit autophagy, thereby influencing the efficacy of cancer treatments.

Conclusions:

• lncRNAs play a pivotal role in cancer chemoresistance and radioresistance by fine-tuning the autophagy pathway.
• Targeting lncRNA-autophagy interactions presents a promising strategy for developing novel therapeutic approaches to overcome cancer therapy resistance.
• Further investigation into the precise mechanisms of lncRNA regulation of autophagy could identify new autophagy-related therapeutic targets for cancer treatment.